Copner Biotech scoops SME News Visionary Leadership Award
Copner Biotech are pleased to announce that we have been awarded the "Bioprinter Innovation Excellence Award 2025"...
Copner Biotech are pleased to announce that we have been awarded the "Bioprinter Innovation Excellence Award 2025"...
Copner Biotech's CEO and CTO attend Keele University to demonstrate our 3D Cell Culture and Biofabrication technology;
many thanks to Professor Ying Yang for organising this event and being such a great host...
Copner Biotech are proud to be collaborating with Glasgow University on this cutting
edge research into treatments for Prostate Cancer...
Copner Biotech awarded three Business Development Grants from Blaenau Gwent.
These grants will be instrumental in upgrading our current extrusion bioprinter, the GRAPE-S1,
to include a built-in clean room environment and new software features. Additionally,
the funding will assist us to consolidate our intellectual property portfolio to include
European and US patents to run along side our UK patents.
Copner Biotech's CFO Elizabeth Copner FCCA FMAAT selected as a finalist for the Chief Financial Officer/Finance Director of the Year; sponsored by Principality Building Society.
Copner Biotech's CTO and CFO honoured to be invited to the St David's Day Reception fostering ties and opportunities
between Denmark and Wales held at the British Embassy Copenhagen.
Copner Biotech's product portfolio as featured in Beijing news media; leads the way in 3D cell culture and tissue regeneration...
The company’s new proprietary GRAPE® 3D modeling format enables users to model and
print highly accurate 3D constructs with high batch consistency. With Copner Biotech’s
next-generation 3D modeling software, users can directly design and create complex
microstructures suitable for 3D cell culture and tissue engineering applications
GRAPE® Technology - Renderable Biofabrication®